Browsing by Author "Frazier-Mills, Camille G"
Now showing 1 - 4 of 4
- Results Per Page
- Sort Options
Item Open Access 2023 HRS/EHRA/APHRS/LAHRS Expert Consensus Statement on Practical Management of the Remote Device Clinic.(Journal of arrhythmia, 2023-06) Ferrick, Aileen M; Raj, Satish R; Deneke, Thomas; Kojodjojo, Pipin; Lopez-Cabanillas, Nestor; Abe, Haruhiko; Boveda, Serge; Chew, Derek S; Choi, Jong-Il; Dagres, Nikolaos; Dalal, Aarti S; Dechert, Brynn E; Frazier-Mills, Camille G; Gilbert, Olivia; Han, Janet K; Hewit, Sherri; Kneeland, Christine; Mirza, Starr DeEllen; Mittal, Suneet; Ricci, Renato Pietro; Runte, Mary; Sinclair, Susan; Alkmim-Teixeira, Ricardo; Vandenberk, Bert; Varma, Niraj; Document Reviewers; Davenport, Elizabeth; Freedenberg, Vicki; Glotzer, Taya V; Huang, Jin-Long; Ikeda, Takanori; Kramer, Daniel B; Lin, David; Rojel-Martínez, Ulises; Stühlinger, Markus; Varosy, Paul DRemote monitoring is beneficial for the management of patients with cardiovascular implantable electronic devices by impacting morbidity and mortality. With increasing numbers of patients using remote monitoring, keeping up with higher volume of remote monitoring transmissions creates challenges for device clinic staff. This international multidisciplinary document is intended to guide cardiac electrophysiologists, allied professionals, and hospital administrators in managing remote monitoring clinics. This includes guidance for remote monitoring clinic staffing, appropriate clinic workflows, patient education, and alert management. This expert consensus statement also addresses other topics such as communication of transmission results, use of third-party resources, manufacturer responsibilities, and programming concerns. The goal is to provide evidence-based recommendations impacting all aspects of remote monitoring services. Gaps in current knowledge and guidance for future research directions are also identified.Item Open Access 2023 HRS/EHRA/APHRS/LAHRS Expert Consensus Statement on Practical Management of the Remote Device Clinic.(Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2023-05) Ferrick, Aileen M; Raj, Satish R; Deneke, Thomas; Kojodjojo, Pipin; Lopez-Cabanillas, Nestor; Abe, Haruhiko; Boveda, Serge; Chew, Derek S; Choi, Jong-Il; Dagres, Nikolaos; Dalal, Aarti S; Dechert, Brynn E; Frazier-Mills, Camille G; Gilbert, Olivia; Han, Janet K; Hewit, Sherri; Kneeland, Christine; Mirza, Starr DeEllen; Mittal, Suneet; Ricci, Renato Pietro; Runte, Mary; Sinclair, Susan; Alkmim-Teixeira, Ricardo; Vandenberk, Bert; Varma, Niraj; Davenport, Elizabeth; Freedenberg, Vicki; Glotzer, Taya V; Huang, Jin-Long; Ikeda, Takanori; Kramer, Daniel B; Lin, David; Rojel-Martínez, Ulises; Stühlinger, Markus; Varosy, Paul DRemote monitoring is beneficial for the management of patients with cardiovascular implantable electronic devices by impacting morbidity and mortality. With increasing numbers of patients using remote monitoring, keeping up with higher volume of remote monitoring transmissions creates challenges for device clinic staff. This international multidisciplinary document is intended to guide cardiac electrophysiologists, allied professionals, and hospital administrators in managing remote monitoring clinics. This includes guidance for remote monitoring clinic staffing, appropriate clinic workflows, patient education, and alert management. This expert consensus statement also addresses other topics such as communication of transmission results, use of third-party resources, manufacturer responsibilities, and programming concerns. The goal is to provide evidence-based recommendations impacting all aspects of remote monitoring services. Gaps in current knowledge and guidance for future research directions are also identified.Item Open Access Syncope Recurrence and Downstream Diagnostic Testing after Insertable Cardiac Monitor Placement for Syncope.(Diagnostics (Basel, Switzerland), 2022-08) Frazier-Mills, Camille G; Johnson, Lawrence C; Xia, Ying; Rosemas, Sarah C; Franco, Noreli C; Pokorney, Sean DDespite advances in syncope evaluation strategies and risk stratification, the high cost of syncope is largely driven by extensive and often repetitive testing. This analysis of a large deidentified US claims database compared the use of diagnostic tests, therapeutic procedures, and the recurrence rate of acute syncope events before and after placement of an insertable cardiac monitor (ICM) in syncope patients. The patients had a minimum of 1 year of continuous enrollment before and 2 years after ICM placement. Among 2140 patients identified, a statistically significant reduction in the use of 14 out of 18 tests was observed during follow-up compared with pre-ICM testing. During the 2-year follow-up, 28.3% of patients underwent cardiac therapeutic interventions after a median of 127 days. Significantly fewer patients experienced acute syncope events during the 1st and 2nd years of ICM follow-up compared with the 1-year pre-ICM period, and the frequency of events per patient also decreased. In conclusion, reductions in diagnostic testing and acute syncope events were observed after ICM placement in a large real-world cohort of unexplained syncope patients. Further studies are needed to prospectively assess the impact of ICM vs. short-term monitoring on patient outcomes and healthcare utilization.Item Open Access VVI pacing with normal QRS duration and ventricular function: MOST trial findings relevant to leadless pacemakers.(Pacing and clinical electrophysiology : PACE, 2020-12) Loring, Zak; North, Rebecca; Hellkamp, Anne S; Atwater, Brett D; Frazier-Mills, Camille G; Jackson, Kevin P; Pokorney, Sean D; Lamas, Gervasio A; Piccini, Jonathan PBackground
Leadless pacemakers (LPs) provide ventricular pacing without the risks associated with transvenous leads and device pockets. LPs are appealing for patients who need pacing, but do not need defibrillator or cardiac resynchronization therapy. Most implanted LPs provide right ventricular pacing without atrioventricular synchrony (VVIR mode). The Mode Selection Trial in Sinus Node Dysfunction (MOST) showed similar outcomes in patients randomized to dual-chamber (DDDR) versus ventricular pacing (VVIR). We compared outcomes by pacing mode in LP-eligible patients from MOST.Methods
Patients enrolled in the MOST study with an left ventricular ejection fraction (LVEF) >35%, QRS duration (QRSd) <120 ms and no history of ventricular arrhythmias or prior implantable cardioverter defibrillators were included (LP-eligible population). Cox proportional hazards models were used to test the association between pacing mode and death, stroke or heart failure (HF) hospitalization and atrial fibrillation (AF).Results
Of the 2010 patients enrolled in MOST, 1284 patients (64%) met inclusion criteria. Baseline characteristics were well balanced across included patients randomized to DDDR (N = 630) and VVIR (N = 654). Over 4 years of follow-up, there was no association between pacing mode and death, stroke or HF hospitalization (VVIR HR 1.28 [0.92-1.75]). VVIR pacing was associated with higher risk of AF (HR 1.32 [1.08-1.61], P = .007), particularly in patients with no history of AF (HR 2.38 [1.52-3.85], P < .001).Conclusion
In patients without reduced LVEF or prolonged QRSd who would be eligible for LP, DDDR, and VVIR pacing demonstrated similar rates of death, stroke or HF hospitalization; however, VVIR pacing significantly increased the risk of AF development.